The original lawsuit claimed the man had become seriously ill after taking Accutane, a drug manufactured by the New Jersey-based pharmaceutical company for the treatment of acne. It further claimed the company did not properly disclose the potential effects and health risks of the drug.
The man was awarded damages in 2010. An appellate court overturned the verdict stating the lawsuit was filed too late under Alabama law.
Last week, the New Jersey Supreme Court reversed the appellate panel’s ruling, reinstating the jury award. For additional details, read “NJ court gives man $25 M award in acne drug case.”